Combined Drug-Radiation Treatment:
Biolgical Basis, current applications & perspective
Gdansk, Poland
17-20 March 2012
Extended early rate deadline:
21 December 2011
▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬
Course Director
Jacek Jassem, Radiation Oncologist, Akademia Medyczna, Gdansk (PL)
Teachers
The course faculty includes international experts from the various “bench to bedside” fields which will allow a high level of interaction between teachers and participants.
Rafal Dziadziuszko, Radiation Oncologist, Academia Medyczna, Gdansk (PL)
Robert Glynne-Jones, Clinical Oncologist, Mount Vernon Cancer Centre, Northwood (GB)
Christophe Hennequin, Radiation Oncologist, Hopital Saint-Louis, Paris (FR)
Barbara Jereczek-Fossa, Radiation Oncologist, University of Milan - European Institute of Oncology, Milan (IT)
Eric Lartigau, Radiation Oncologist, Centre Oscar Lambret, Lille (FR)
Roger Stupp, Medical Oncologist, Multidisciplinary Oncology Centre, University Hospital (CHUV), Lausanne (CH)
Local Organiser
Jacek Jassem, Radiation Oncologist & Medical Oncologist, Medical Faculty, Gdansk (PL)
Anna Kowalczyk, Radiation Oncologist, Medical University, Gdansk (PL)
Course rationale
Effective cancer treatment necessitates both high efficacy of local treatment and combating sub-clinical systemic disease. Consequently, cancer therapy today involves various combinations of local and systemic treatment modalities. Of those, combining drugs and radiation has been attracting particular attention both in terms of its biological rationale and its potential of increasing the therapeutic outcome. The course aims at updating participants about established and emerging knowledge in this field. It will provide the key-messages that biological and clinical research is bringing to the oncology community nowadays.
Course Aims
-
To update participants about biological effects of combining drugs and radiation in normal and tumour tissue
-
Presenting evidence-based clinical applications of combined modality treatment using drugs and radiation in major human malignancies
-
Stimulating case-based discussion on the interdisciplinary treatment of cancer
-
Presenting future perspectives for combining drugs and radiation
Target Group
The course is aimed at radiation oncologists and medical oncologists involved in the multidisciplinary treatment of cancer.
Educational programme
General lectures
· Biologic basis for combining drugs with radiation
· Combining drugs with radiation: Quantifying the therapeutic gain
· Combining new drugs with radiotherapy
· Radiation and non-cytotoxic drugs
· Hypoxic cell radiosensitizers
· Cytoprotective agents and radiotherapy: what is safe and what is not?
· Alteration of radiotherapy fractionation and concurrent chemotherapy
· Designing clinical trials for combined modality treatments
Site specific lectures including practical case discussions
· Personalizing cancer therapy: rationale and challenges
· Head and neck cancer
· Non small cell lung cancer
· Small cell lung cancer
· Breast cancer
· Prostate cancer
· Bladder cancer
· Cervical cancer
· Oesophageal cancer
· Rectal cancer
· Anal canal
· Pancreas
· Gastric cancer
· Brain tumours
· Lymphomas